Caudal Epidural Steroid Injection and Eliquis (Apixaban)
A caudal epidural steroid injection is NOT absolutely contraindicated in patients taking Eliquis (apixaban), but the medication must be held for 24-48 hours prior to the procedure to minimize the risk of epidural hematoma, which can cause permanent paralysis.
Key Recommendation Based on Guidelines
The most recent and authoritative guidance comes from the 2017 French Working Group on Perioperative Hemostasis 1, which classifies neuraxial anesthesia/puncture (including epidural injections) as very high hemorrhagic risk procedures. This guideline explicitly states:
- Apixaban prophylaxis requires 24-48 hours of discontinuation before neuraxial procedures 2
- The entire group strongly recommends NOT performing spinal or epidural anesthesia or deep-block techniques in patients with possible DOA (direct oral anticoagulant) concentration 1
- For very high hemorrhagic risk procedures like neuraxial puncture, interruption time should be up to 5 days for xabans (including apixaban) in the absence of renal failure 1
Critical Safety Considerations
Timing of Apixaban Discontinuation
The 2013 UK guidelines 2 specify for apixaban prophylaxis:
- Minimum 24-48 hours before block performance
- Peak effect occurs at 3-4 hours
- Half-life is 12 hours
- NOT recommended to give while epidural catheter is in place
- Wait 6 hours after catheter removal before restarting
Patient-Specific Factors That Extend Holding Time
You must assess:
- Renal function (creatinine clearance): Apixaban has renal elimination; reduced CrCl requires longer holding periods
- Age: Elderly patients (>80 years) may have delayed drug clearance
- Concomitant medications: P-glycoprotein inhibitors or CYP3A4 inhibitors increase apixaban levels and require longer discontinuation 1
- Body weight: Patients <60 kg may have higher drug concentrations
The Catastrophic Risk: Epidural Hematoma
The FDA drug label for Eliquis 3 contains a black box warning about spinal/epidural hematomas:
- Risk of long-term or permanent paralysis with neuraxial anesthesia or spinal puncture in anticoagulated patients
- Risk is higher with:
- Epidural catheters
- Concomitant NSAIDs or other anticoagulants
- History of difficult/traumatic spinal procedures
- Spinal deformity or prior spine surgery
The FDA explicitly warns: "Tell your doctor right away if you have tingling, numbness, or muscle weakness, especially in your legs and feet" after neuraxial procedures 3.
Emerging Evidence on Caudal ESI Safety
While one 2021 retrospective study 4 reported no complications in 392 caudal ESIs performed on patients remaining on antithrombotics, this evidence cannot override guideline recommendations because:
- It was retrospective with 51 encounters lost to follow-up
- Complications were based only on patient self-report without imaging
- The study did not specify which patients were on DOACs versus other antithrombotics
- Multiple case reports exist of epidural hematomas despite following guidelines 5, 6
The risk of catastrophic neurological injury, though rare, outweighs the inconvenience of temporarily holding anticoagulation.
Practical Algorithm for Caudal ESI in Patients on Eliquis
Step 1: Risk-Benefit Assessment
- Determine indication for Eliquis (atrial fibrillation, VTE treatment, VTE prophylaxis)
- Assess stroke/thrombosis risk if medication is held
- Consider if caudal ESI is truly necessary or if alternative treatments exist
Step 2: Coordinate with Prescribing Physician
- Do not proceed without cardiology/hematology consultation for high-risk patients (recent stroke, mechanical valve, recent VTE)
- Most patients can safely hold Eliquis for 2-5 days
Step 3: Determine Holding Period
- Standard dose (5 mg BID): Hold for 48 hours minimum (4 half-lives)
- If CrCl 30-50 mL/min: Hold for 72 hours
- If age >80 or on P-gp inhibitors: Hold for 72 hours
- If traumatic procedure anticipated or patient has spinal abnormalities: Consider holding for 5 days 1
Step 4: Verify Adequate Washout
- Check recent creatinine and calculate CrCl
- Confirm last dose timing with patient
- Consider anti-Xa level if available and high-risk patient
Step 5: Post-Procedure Restart
- Wait minimum 6 hours after needle removal 2
- If procedure was traumatic or bloody, consider waiting 12-24 hours
- Bridge with mechanical prophylaxis (compression devices) if needed
- Do not use heparin bridging unless extremely high thrombotic risk 1
Step 6: Monitor for Complications
- Educate patient on warning signs: leg weakness, numbness, bowel/bladder dysfunction
- Ensure 24-hour contact availability
- Lower threshold for urgent MRI if any neurological symptoms develop
Common Pitfalls to Avoid
- Assuming "prophylactic dose" is safe: Even low-dose apixaban requires 24-48 hour holding 2
- Not checking renal function: Apixaban accumulates in renal impairment
- Proceeding because "the patient needs pain relief": Paralysis is worse than temporary pain
- Restarting too early: The 6-hour minimum is critical 2
- Not documenting informed consent: Patient must understand paralysis risk
When to Absolutely Refuse the Procedure
- Patient cannot or will not hold Eliquis
- Inadequate holding time (<24 hours for normal renal function)
- Unknown last dose timing
- Severe renal impairment (CrCl <30) without extended holding period
- Patient on multiple anticoagulants/antiplatelets
- Recent epidural hematoma history
The medicolegal and clinical consequences of causing paralysis far exceed any benefit from performing the injection while inadequately anticoagulated.